Cargando…
Stem Cell Biomarkers in Chronic Myeloid Leukemia
Chronic myeloid leukemia (CML) is a clonal multi-step myeloproliferative disease that is initially produced and ultimately sustained by a rare subpopulation of BCR-ABL(+) cells with multi-lineage stem cell properties. These BCR-ABL(+) CML stem cells are phenotypically similar to normal hematopoietic...
Autores principales: | Jiang, Xiaoyan, Zhao, Yun, Forrest, Donna, Smith, Clayton, Eaves, Allen, Eaves, Connie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850599/ https://www.ncbi.nlm.nih.gov/pubmed/18525114 http://dx.doi.org/10.1155/2008/146871 |
Ejemplares similares
-
An approach to the management of chronic myeloid leukemia in British Columbia
por: Forrest, D.L., et al.
Publicado: (2008) -
Expression of the leukemic prognostic marker CD7 is linked to epigenetic modifications in chronic myeloid leukemia
por: Rogers, Sally L, et al.
Publicado: (2010) -
Targeting Primitive Chronic Myeloid Leukemia Cells by Effective Inhibition of a New AHI-1–BCR-ABL–JAK2 Complex
por: Chen, Min, et al.
Publicado: (2013) -
Growth Arrest Specific 2 Is Up-Regulated in Chronic Myeloid Leukemia Cells and Required for Their Growth
por: Zhou, Haixia, et al.
Publicado: (2014) -
Cancer Stem Cells: Notes for Authors
por: Eaves, Connie J., et al.
Publicado: (2020)